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Reduced autophagy has been implicated in aging, yet whether its loss can promote aging 24 
phenotypes and pathologies in mammals, and how reversible this process is, has never been 25 
fully explored. Using inducible short hairpin RNA (shRNA) mouse models, we have recently 26 
shown that autophagy inhibition accelerates aging, and that even a temporary block in 27 
autophagy can create irreversible damage that increases a cancer risk.  28 
 29 
Aging is associated with a loss of proteostasis, organelle homeostasis, as well as an 30 
accumulation of damaged and misfolded aggregates1 Thus, it is no surprise that increasing age 31 
is associated with a corresponding decrease in autophagy. Whilst conventional and conditional 32 
knockout mouse models of essential autophagy genes have provided important insights into 33 
the role of autophagy in development and disease, aging studies have been difficult to perform 34 
either due to the associated neonatal lethality, or the rapid adult neurotoxicity that inevitably 35 
occurs with systemic autophagy loss.2,3 36 
 37 
Despite the technical limitations to explore autophagy and aging in mammalian systems, 38 
numerous studies have provided supportive evidence that regimens intended to promote 39 
autophagy, both through lifestyle (dietary restriction) and pharmacological modulation, can 40 
promote health-span.4,5 However, these approaches are pleiotropic in nature, often promoting 41 
autophagy through upstream mechanisms that impinge upon additional signaling cascades. 42 
Recently, two genetic studies have shown that by promoting autophagy constitutively, mice 43 
display an increased health-span and reduced rates of spontaneous tumorigenesis.6,7 Together 44 
these data provide compelling evidence that pharmacological modulation of autophagy may 45 



































































In our recent publication, we attempted to provide answers to some of the outstanding questions 48 
that remain in the field of autophagy and mammalian aging. The first was simply, is a systemic 49 
reduction in autophagic flux enough to promote aging and age-related phenotypes in a 50 
mammalian system? Whilst the second was, if yes then are these effects reversible by 51 
restoration of autophagy? This latter point is of importance as it argues for the correct timepoint 52 
of intervention. Is it possible to reverse pathological phenotypes, or is it more effective to 53 
prevent the damage from ever accruing? 54 
 55 
To circumvent the limitations imposed by traditional (systemic) knockout mice, we employed 56 
doxycycline-inducible short hairpin RNA (shRNA) models to achieve body-wide temporal 57 
control of autophagy through the targeting of Autophagy-related 5 (Atg5), an essential 58 
autophagy component ( e med A g5i  mice). A major caveat of our inducible system is that 59 
doxycycline is poorly permeable across the blood-brain-barrier and as such the system shows 60 
no activation in the brain, leaving autophagy intact in this organ.8 We realized that this 61 
discrepancy of system activation provided us with a unique opportunity to perform long-term, 62 
systemic  autophagy experiments without the associated neurotoxic effects seen in whole-63 
body knockout models (e.g. systemic Autophagy-related 7 [Atg7] knockout in adult mice leads 64 
to death between 2 to 3 months3). Furthermore, we have developed two models with shRNAs 65 
of different inhibition efficiencies. The original Atg5i mice provided a knockdown efficiency 66 
that generated gross phenotypes akin to those seen in knockout mice (hepatomegaly and 67 
splenomegaly)8, whilst the second hairpin mouse line (termed Atg5i-2) was hypomorphic, 68 
leading to a reduction in autophagy without these obvious associated pathologies.9 69 
 70 
In our latest work, Atg5i mice were aged until eight-weeks old, to separate out developmental 71 


































































inhibit autophagy.9 As expected, although they survive premature death due to the neuronal 73 
toxicity, mice with autophagy inhibition still displayed dramatically reduced life-spans 74 
compared to normal mice in b h he hRNA  e ed (Atg5i median survival 185 days). 75 
Furthermore, they displayed evidence of phenotypes that occur with increasing age such as 76 
greying, kyphosis, loss of muscle mass, and evidence of autoimmunity. Molecular markers of 77 
aging, including inflammatory cytokines, telomere-associated DNA damage, and markers of 78 
senescence in various tissues were also elevated in our autophagy inhibited mice. Together, the 79 
study provides evidence that loss of autophagy systemically induces molecular, cellular, and 80 
organismal phenotypes that are strongly associated with increasing age. Whilst we were unable 81 
to determine a singular cause of death to contributed to mortality in our Atg5i mice (as the 82 
cause of death appears to be non-uniform), we view this as a positive outcome for the model. 83 
Aging is a complex and multifaceted process that is associated with some degree of 84 
stochasticity, this process at least appears to be recapitulated in our Atg5i mice. Note similar 85 
aging phenotypes were observed in Atg5i-2 (median survival 240 days), suggesting that a 86 
modest decrease in autophagy reduction is sufficient for age acceleration. 87 
 88 
Using the Atg5i mice, we next approached our second question and inhibited autophagy in 89 
mice for four months, wherein Atg5i mice would universally display aging phenotypes and an 90 
increase in frailty. At this timepoint, we removed doxycycline from the diet and restored 91 
autophagy levels. Strikingly, mice showed a gross recovery in frailty and a dramatic recovery 92 
in their health- and life-span. However, we also noted that kyphosis and greying phenotypes 93 
were largely, if not completely, irreversible, whilst the molecular damage that had accumulated 94 
(such as telomere-associated DNA damage) was also irremediable. Thus, although 95 
encouraging from a translatable aspect, it is important to note that not all damage induced by 96 


































































of reduced autophagy was associated with an increased incidence of spontaneous tumor 98 
formation, suggesting that this irreversible damage can be tumorigenic in nature. We speculate 99 
that preventing damage through the promotion of autophagy would be more beneficial than 100 
late-stage restoration. 101 
 102 
Overall our study provides missing data further linking autophagy and mammalian aging, 103 
whilst at the same time exploring the timing and efficacy of autophagy restoration therapies on 104 
aging pathologies. Importantly our work also provides supportive evidence for a biphasic role 105 
of autophagy in cancer development (Fig. 1). Wherein a reduction in autophagy is associated 106 
with the accumulation of pro-tumorigenic damage and possibly the establishment of 107 
premalignant disease without further progression, at least in the liver as previously reported.10 108 
Once the irreversible damage has accumulated, a tumorous cell that has re-established 109 
autophagic flux would undoubtedly have a fitness advantage, as autophagy is important for 110 
basic cellular homeostasis. Although it should be noted that our work does not conclusively 111 
prove this and further studies would be required. These results also raise the specter of long-112 
term cancer risk in the setting of early life autophagy inhibition, such as childhood obesity. 113 
Further studies, both in mice and epidemiologically in humans, would add welcome real-world 114 
data to support or refute these possibilities. 115 
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Figure 1. Potential impact of autophagy modulation on aging and tumorigenesis 148 
(1) Autophagy is required to maintain normal tissue and organismal homeostasis. (2) Loss of 149 
autophagy induces premature aging phenotypes, which is associated with cellular dysfunction. 150 
(3) The restoration of autophagy leads to the gross recovery of cellular and organismal 151 
homeostasis. However, some effects are irreversible, such as genomic damage. We speculate 152 
that the accumulation of this irreversible damage may accelerate the development of 153 





















































































Figure 1. Potential impact of autophagy modulation on aging and tumorigenesis
(1) Autophagy is required to maintain normal tissue and organismal homeostasis. (2) Loss of autophagy induces premature 
aging phenotypes, which is associated with cellular dysfunction. (3) The restoration of autophagy leads to the gross recovery of 
cellular and organismal homeostasis. However, some effects are irreversible, such as genomic damage. We speculate that the 
accumulation of this irreversible damage may accelerate the development of spontaneous tumor formation in the presence of 
the intact autophagy flux.
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